社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Liminatus Pharma LLC(LIMN)
0.5806
-0.6794
-53.92%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
Liminatus Pharma LLC 将以发行400万股普通股换取持有者交回并注销805,377份认股权证
美股速递 · 02-10 04:05
Liminatus Pharma LLC 将以发行400万股普通股换取持有者交回并注销805,377份认股权证
Liminatus Pharma, Inc.盘中异动 股价大涨24.83%报1.79美元
市场透视 · 02-05
Liminatus Pharma, Inc.盘中异动 股价大涨24.83%报1.79美元
Liminatus Pharma, Inc.盘中异动 股价大涨15.04%报1.23美元
市场透视 · 02-04
Liminatus Pharma, Inc.盘中异动 股价大涨15.04%报1.23美元
Liminatus Pharma, Inc.盘中异动 急速拉升5.51%
市场透视 · 2025-11-10
Liminatus Pharma, Inc.盘中异动 急速拉升5.51%
Liminatus Pharma, Inc. (Nasdaq: Limn) 与 Capital Trust Group 签署3000万美元权益投资谅解备忘录，采用盈余转化机制并探讨未来战略合作
美股速递 · 2025-10-30
Liminatus Pharma, Inc. (Nasdaq: Limn) 与 Capital Trust Group 签署3000万美元权益投资谅解备忘录，采用盈余转化机制并探讨未来战略合作
公司概况
公司名称
Liminatus Pharma LLC
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
- -
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Liminatus Pharma, Inc.是一家特拉华州公司，成立于2022年11月23日。Liminatus是一家临床前阶段的生物制药公司，开发新型的免疫调节癌症疗法。公司候选IBA101，是一种人源化抗CD47单抗。下一代CD47检查点抑制剂的初步适应症预计为包括非小细胞肺癌在内的晚期实体癌患者。作为一家全球领先的生物制药公司，该公司的愿景是为癌症患者开发一系列广泛的变革性疗法。
02-11 13:00
招股说明书
Form S-1 - General form for registration of securities under the Securities Act of 1933
Form S-1 - General form for registration of securities under the Securities Act of 1933
02-09 13:00
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
01-26
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-11-25
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-11-14
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-10-06
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-08-25
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-08-15
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-08-12
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
2025-07-26
[修订]招股说明书
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025-07-26
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
2025-07-17
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-07-11
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-07-03
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-06-24
招股说明书
Form S-1 - General form for registration of securities under the Securities Act of 1933
Form S-1 - General form for registration of securities under the Securities Act of 1933
分时
5日
日
周
月
数据加载中...
最高
1.10
今开
1.07
量比
0.36
最低
0.5805
昨收
1.26
换手率
276.89%
热议股票
{"pagemeta":{"title":"Liminatus Pharma LLC(LIMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Liminatus Pharma LLC(LIMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Liminatus Pharma LLC,LIMN,Liminatus Pharma LLC股票,Liminatus Pharma LLC股票老虎,Liminatus Pharma LLC股票老虎国际,Liminatus Pharma LLC行情,Liminatus Pharma LLC股票行情,Liminatus Pharma LLC股价,Liminatus Pharma LLC股市,Liminatus Pharma LLC股票价格,Liminatus Pharma LLC股票交易,Liminatus Pharma LLC股票购买,Liminatus Pharma LLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Liminatus Pharma LLC(LIMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Liminatus Pharma LLC(LIMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"news","symbol":"LIMN","data":{"stockData":{"symbol":"LIMN","market":"US","secType":"STK","nameCN":"Liminatus Pharma LLC","latestPrice":0.5806,"timestamp":1770833091607,"preClose":1.26,"halted":0,"volume":12474416,"delay":0,"changeRate":-0.5392063492063492,"floatShares":4505200,"shares":27064633,"eps":-0.01953,"marketStatus":"交易中","change":-0.6794,"latestTime":"02-11 13:04:55 EST","open":1.07,"high":1.1,"low":0.5805,"amount":9772321.5232656,"amplitude":0.412302,"askPrice":0.5915,"askSize":261,"bidPrice":0.5739,"bidSize":48,"shortable":0,"etf":0,"ttmEps":-0.01953,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770843600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1.26,"preHourTrading":{"tag":"盘前","latestPrice":1.0999,"preClose":1.26,"latestTime":"09:29 EST","volume":691029,"amount":787014.1719522,"timestamp":1770820182760,"change":-0.1601,"changeRate":-0.127063,"amplitude":0.230159},"postHourTrading":{"tag":"盘后","latestPrice":1.22,"preClose":1.26,"latestTime":"19:59 EST","volume":323544,"amount":403357.0956,"timestamp":1770771594600,"change":-0.04,"changeRate":-0.031746,"amplitude":0.063492},"volumeRatio":0.360976},"tweetData":null,"newsData":{"listData":[{"id":"1154592636","title":"Liminatus Pharma LLC 将以发行400万股普通股换取持有者交回并注销805,377份认股权证","url":"https://stock-news.laohu8.com/highlight/detail?id=1154592636","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154592636?lang=zh_cn&edition=full","pubTime":"2026-02-10 04:05","pubTimestamp":1770667513,"startTime":"0","endTime":"0","summary":"Liminatus Pharma LLC 宣布了一项资本结构调整方案。根据协议，该公司将向特定权证持有者发行总计400万股普通股。作为交换，持有者需交回并注销其持有的805,377份认股权证。\n此项交易旨在优化公司的资本结构，并简化股权工具。通过以股份置换权证，公司可以巩固股权基础，并可能减少未来因权证行权导致的潜在股权稀释。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIMN","BK4139"],"gpt_icon":0},{"id":"2609532153","title":"Liminatus Pharma, Inc.盘中异动 股价大涨24.83%报1.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609532153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609532153?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:40","pubTimestamp":1770302421,"startTime":"0","endTime":"0","summary":"北京时间2026年02月05日22时40分，Liminatus Pharma, Inc.股票出现异动，股价大幅拉升24.83%。截至发稿，该股报1.79美元/股，成交量923.402万股，换手率34.12%，振幅27.97%。Liminatus Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。其相关个股中，Aim Immunotech Inc.、Transcode Therapeutics, Inc.、Fibrobiologics, Inc.涨幅较大，Aim Immunotech Inc.、Transcode Therapeutics, Inc.、Propanc Biopharma, Inc.较为活跃，换手率分别为1339.54%、924.71%、190.65%，振幅较大的相关个股有Aim Immunotech Inc.、Bone Biologics Corp C/Wts 13/10/2026 、Liminatus Pharma, Inc.，振幅分别为37.91%、28.16%、27.97%。Liminatus Pharma, Inc.公司简介：Liminatus Pharma Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020522402197a50dbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020522402197a50dbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIMN","BK4139"],"gpt_icon":0},{"id":"2609390221","title":"Liminatus Pharma, Inc.盘中异动 股价大涨15.04%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609390221","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609390221?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:31","pubTimestamp":1770215485,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日22时31分，Liminatus Pharma, Inc.股票出现波动，股价急速拉升15.04%。截至发稿，该股报1.23美元/股，成交量861.126万股，换手率31.82%，振幅14.90%。Liminatus Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Liminatus Pharma, Inc.、Oncolytics Biotech Inc.、Xtl生物制药涨幅较大，Biodexa Pharmaceuticals Plc、Gri Bio, Inc.、Evogene Ltd.较为活跃，换手率分别为341.37%、180.51%、93.96%，振幅较大的相关个股有Liminatus Pharma Inc C/Wts 30/04/2030 、Liminatus Pharma, Inc.、Bioatla, Inc.，振幅分别为18.20%、14.90%、14.07%。Liminatus Pharma, Inc.公司简介：Liminatus Pharma Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204223125a6d344d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204223125a6d344d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LIMN"],"gpt_icon":0},{"id":"2582333749","title":"Liminatus Pharma, Inc.盘中异动 急速拉升5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582333749","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582333749?lang=zh_cn&edition=full","pubTime":"2025-11-10 22:40","pubTimestamp":1762785653,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日22时40分，Liminatus Pharma, Inc.股票出现波动，股价大幅上涨5.51%。Liminatus Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，Cogent Biosciences, Inc.、Inflarx N.V.、Pluri Inc.涨幅较大，Inflarx N.V.、Propanc Biopharma, Inc.、Innate Pharma较为活跃，换手率分别为78.83%、15.33%、8.72%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Cogent Biosciences, Inc.、Pluri Inc.，振幅分别为22.10%、20.18%、20.06%。Liminatus Pharma, Inc.公司简介：Liminatus Pharma Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110224054a6efc267&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110224054a6efc267&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LIMN","BK4139"],"gpt_icon":0},{"id":"1108702828","title":"Liminatus Pharma, Inc. (Nasdaq: Limn) 与 Capital Trust Group 签署3000万美元权益投资谅解备忘录，采用盈余转化机制并探讨未来战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1108702828","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108702828?lang=zh_cn&edition=full","pubTime":"2025-10-30 22:05","pubTimestamp":1761833112,"startTime":"0","endTime":"0","summary":"Liminatus Pharma, Inc. (Nasdaq: Limn) 与 Capital Trust Group 签署了一项谅解备忘录，以通过盈余转化机制进行3000万美元的权益投资，并探讨未来的战略合作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LIMN","BK4139"],"gpt_icon":0}],"currentPage":1,"bottom":true},"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"20724088","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465926012942-LIMN","pdf_url":"","pub_time":1770786000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1 - General form for registration of securities under the Securities Act of 1933","symbol":"LIMN","title":"Form S-1 - General form for registration of securities under the Securities Act of 1933","titleType":"招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926012942/0001104659-26-012942-index.htm","us_notice_code":"Form S-1","us_title_en":"Form S-1 - General form for registration of securities under the Securities Act of 1933","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926012942/limn-20250930xs1.htm","primary":true,"translateUrl":"","linkName":"limn-20250930xs1.htm","type":"S-1","id":"NTFILEEhcgBKQ9DQFrLwYw","market":"us","size":3319238},{"description":"EX-4.5","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926012942/limn-20250930xex4d5.htm","primary":false,"translateUrl":"","linkName":"limn-20250930xex4d5.htm","type":"EX-4.5","id":"NTFILEBLcphrYSVavMCkuk","market":"us","size":184222},{"description":"EX-4.6","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926012942/limn-20250930xex4d6.htm","primary":false,"translateUrl":"","linkName":"limn-20250930xex4d6.htm","type":"EX-4.6","id":"NTFILEFs4B2xzrzqK8GxHG","market":"us","size":119502},{"description":"EX-4.7","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926012942/limn-20250930xex4d7.htm","primary":false,"translateUrl":"","linkName":"limn-20250930xex4d7.htm","type":"EX-4.7","id":"NTFILE35wRUBemZizZ7zKF","market":"us","size":118268},{"description":"EX-4.8","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926012942/limn-20250930xex4d8.htm","primary":false,"translateUrl":"","linkName":"limn-20250930xex4d8.htm","type":"EX-4.8","id":"NTFILE3UPsR2BPGZfsGYVQ","market":"us","size":135339},{"description":"EX-5.1","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926012942/limn-20250930xex5d1.htm","primary":false,"translateUrl":"","linkName":"limn-20250930xex5d1.htm","type":"EX-5.1","id":"NTFILEFmmUosgtq2HxkpUC","market":"us","size":17678},{"description":"EX-10.1","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926012942/limn-20250930xex10d1.htm","primary":false,"translateUrl":"","linkName":"limn-20250930xex10d1.htm","type":"EX-10.1","id":"NTFILEBqLuNHAd1NGwSJ8H","market":"us","size":142657},{"description":"EX-10.2","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926012942/limn-20250930xex10d2.htm","primary":false,"translateUrl":"","linkName":"limn-20250930xex10d2.htm","type":"EX-10.2","id":"NTFILEE3Dr5TPVmfodsWtX","market":"us","size":216134},{"description":"EX-10.11","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926012942/limn-20250930xex10d11.htm","primary":false,"translateUrl":"","linkName":"limn-20250930xex10d11.htm","type":"EX-10.11","id":"NTFILEHyFQDvP6QVPRQ67e","market":"us","size":75169},{"description":"EX-23.1","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926012942/limn-20250930xex23d1.htm","primary":false,"translateUrl":"","linkName":"limn-20250930xex23d1.htm","type":"EX-23.1","id":"NTFILE6CP5KTvnKbGYizZu","market":"us","size":2972},{"description":"EX-23.2","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926012942/limn-20250930xex23d2.htm","primary":false,"translateUrl":"","linkName":"limn-20250930xex23d2.htm","type":"EX-23.2","id":"NTFILE2WPo38QrB2ikhxPo","market":"us","size":2966},{"description":"EX-FILING FEES","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926012942/limn-20250930xexfees.htm","primary":false,"translateUrl":"","linkName":"limn-20250930xexfees.htm","type":"EX-FILING FEES","id":"NTFILE2SfH7c8NjBzsigVi","market":"us","size":47971},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926012942/limn-20250930xs1003.jpg","primary":false,"translateUrl":"","linkName":"limn-20250930xs1003.jpg","type":"GRAPHIC","id":"NTFILEAv6Zw85xK1gNUt2M","market":"us","size":15058},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926012942/limn-20250930xs1004.jpg","primary":false,"translateUrl":"","linkName":"limn-20250930xs1004.jpg","type":"GRAPHIC","id":"NTFILE9dt2DJkDX6vBSbbG","market":"us","size":67386},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926012942/limn-20250930xex5d1001.jpg","primary":false,"translateUrl":"","linkName":"limn-20250930xex5d1001.jpg","type":"GRAPHIC","id":"NTFILE8mnMMQmjjvSnJVYT","market":"us","size":7097}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"招股说明书","pubTime":"2026-02-11 13:00","pubTimestamp":1770786000,"title_zh":"Form S-1 - General form for registration of securities under the Securities Act of 1933","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20715628","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465926012016-LIMN","pdf_url":"","pub_time":1770613200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"LIMN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926012016/0001104659-26-012016-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926012016/tm265593d1_8k.htm","primary":true,"translateUrl":"","linkName":"tm265593d1_8k.htm","type":"8-K","id":"NTFILEEBmMLUJfJDrCRyTf","market":"us","size":30882}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-02-09 13:00","pubTimestamp":1770613200,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；第3.02项：未经登记的股本证券销售；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20663892","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465926006619-LIMN","pdf_url":"","pub_time":1769403600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"LIMN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926006619/0001104659-26-006619-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926006619/tm264095d1_8k.htm","primary":true,"translateUrl":"","linkName":"tm264095d1_8k.htm","type":"8-K","id":"NTFILE8EVeQobsW7cVjm7T","market":"us","size":32383}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-01-26 13:00","pubTimestamp":1769403600,"title_zh":"Form 8-K - Current report","summary_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing","summary_zh":"第3.01项：除牌通知或未能符合持续上市规则或标准；转让上市","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20451134","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925116049-LIMN","pdf_url":"","pub_time":1764046800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"LIMN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925116049/0001104659-25-116049-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925116049/tm2532232d1_8k.htm","primary":true,"translateUrl":"","linkName":"tm2532232d1_8k.htm","type":"8-K","id":"NTFILE4YL4JmMzM6A3USE5","market":"us","size":33924}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-11-25 13:00","pubTimestamp":1764046800,"title_zh":"Form 8-K - Current report","summary_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing","summary_zh":"第3.01项：除牌通知或未能符合持续上市规则或标准；转让上市","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20414386","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925111651-LIMN","pdf_url":"","pub_time":1763096400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"LIMN","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925111651/0001104659-25-111651-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925111651/limn-20250930x10q.htm","primary":true,"translateUrl":"","linkName":"limn-20250930x10q.htm","type":"10-Q","id":"NTFILECNMoAWU4bffTsBZC","market":"us","size":1125545},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925111651/limn-20250930xex31d1.htm","primary":false,"translateUrl":"","linkName":"limn-20250930xex31d1.htm","type":"EX-31.1","id":"NTFILEAYbdxGDSQHGPeFGF","market":"us","size":12572},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925111651/limn-20250930xex31d2.htm","primary":false,"translateUrl":"","linkName":"limn-20250930xex31d2.htm","type":"EX-31.2","id":"NTFILE5kbVa1z1CrP3cjsn","market":"us","size":12521},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925111651/limn-20250930xex32d1.htm","primary":false,"translateUrl":"","linkName":"limn-20250930xex32d1.htm","type":"EX-32.1","id":"NTFILEJAnjGmSNecSE8ftH","market":"us","size":6230},{"description":"EX-32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925111651/limn-20250930xex32d2.htm","primary":false,"translateUrl":"","linkName":"limn-20250930xex32d2.htm","type":"EX-32.2","id":"NTFILEAxP2vd3TgWiADfgV","market":"us","size":6162}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-11-14 13:00","pubTimestamp":1763096400,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20241148","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925096872-LIMN","pdf_url":"","pub_time":1759723200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"LIMN","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925096872/0001104659-25-096872-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925096872/limn-20250630x10q.htm","primary":true,"translateUrl":"","linkName":"limn-20250630x10q.htm","type":"10-Q","id":"NTFILE76iR7rcw76DyuEpo","market":"us","size":1110578},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925096872/limn-20250630xex31d1.htm","primary":false,"translateUrl":"","linkName":"limn-20250630xex31d1.htm","type":"EX-31.1","id":"NTFILE4DKmhzs7WG7wcbtq","market":"us","size":13106},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925096872/limn-20250630xex31d2.htm","primary":false,"translateUrl":"","linkName":"limn-20250630xex31d2.htm","type":"EX-31.2","id":"NTFILEFYyrzzy8Xhnc5r2H","market":"us","size":13231},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925096872/limn-20250630xex32d1.htm","primary":false,"translateUrl":"","linkName":"limn-20250630xex32d1.htm","type":"EX-32.1","id":"NTFILEApWNCULGXnG8ZLmQ","market":"us","size":6796},{"description":"EX-32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925096872/limn-20250630xex32d2.htm","primary":false,"translateUrl":"","linkName":"limn-20250630xex32d2.htm","type":"EX-32.2","id":"NTFILEC6HG84PyNjBXw5Zq","market":"us","size":6897}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-10-06 12:00","pubTimestamp":1759723200,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20048746","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925082579-LIMN","pdf_url":"","pub_time":1756094400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"LIMN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925082579/0001104659-25-082579-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 99.7","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925082579/tm2524293d1_ex99-7.htm","primary":true,"translateUrl":"","linkName":"tm2524293d1_ex99-7.htm","type":"EX-99.7","id":"NTFILE66vid9muc2fYq2J1","market":"us","size":6838},{"description":"FORM 8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925082579/tm2524293d1_8k.htm","primary":false,"translateUrl":"","linkName":"tm2524293d1_8k.htm","type":"8-K","id":"NTFILEBC159TPjQnqqMrcX","market":"us","size":32041}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-08-25 12:00","pubTimestamp":1756094400,"title_zh":"Form 8-K - Current report","summary_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第3.01项：除牌通知或未能符合持续上市规则或标准；转让上市；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19991401","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925078577-LIMN","pdf_url":"","pub_time":1755201974000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"LIMN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1971387/0001104659-25-078577-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925078577/tm2523534d1_ex99-1.htm","primary":true,"translateUrl":"","linkName":"tm2523534d1_ex99-1.htm","type":"EX-99.1","id":"NTFILE8nUEKiAhw41JejmM","market":"us","size":9085},{"description":"FORM 8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925078577/tm2523534d1_8k.htm","primary":false,"translateUrl":"","linkName":"tm2523534d1_8k.htm","type":"8-K","id":"NTFILE6AHo37J6Z3dggkuT","market":"us","size":29429}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-08-15 04:06","pubTimestamp":1755201974,"title_zh":"Form 8-K - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第7.01项：法规FD披露；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20194989","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925076067-LIMN","pdf_url":"","pub_time":1754928007000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"LIMN","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1971387/0001104659-25-076067-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925076067/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEDQ2e4PSSaTWSqzkS","market":"us","size":4961}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2025-08-12 00:00","pubTimestamp":1754928007,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19918623","market":"us","labels":[],"media":"sec.gov","original_id":"AN141057825001518-LIMN","pdf_url":"","pub_time":1753495148000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"LIMN","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[修订]招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1971387/0001410578-25-001518-index.html","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-1/A","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001518/limn-20250331xs1a.htm","primary":true,"translateUrl":"","linkName":"limn-20250331xs1a.htm","type":"S-1/A","id":"NTFILE7N2yRYzBRNCaLjKC","market":"us","size":5939636},{"description":"EX-5.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001518/limn-20250331xex5d1.htm","primary":false,"translateUrl":"","linkName":"limn-20250331xex5d1.htm","type":"EX-5.1","id":"NTFILE7iAietWoXU3v54Yh","market":"us","size":19942},{"description":"EX-23.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001518/limn-20250331xex23d1.htm","primary":false,"translateUrl":"","linkName":"limn-20250331xex23d1.htm","type":"EX-23.1","id":"NTFILE6KT1CymBNaHRZB87","market":"us","size":3793},{"description":"EX-23.2","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001518/limn-20250331xex23d2.htm","primary":false,"translateUrl":"","linkName":"limn-20250331xex23d2.htm","type":"EX-23.2","id":"NTFILE7zACPYVAwFRRxZnt","market":"us","size":4716},{"description":"EX-23.3","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001518/limn-20250331xex23d3.htm","primary":false,"translateUrl":"","linkName":"limn-20250331xex23d3.htm","type":"EX-23.3","id":"NTFILE2FKp6tqUSLWxMcYL","market":"us","size":3960},{"description":"EX-FILING FEES","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001518/limn-20250331xexfees.htm","primary":false,"translateUrl":"","linkName":"limn-20250331xexfees.htm","type":"EX-FILING FEES","id":"NTFILEgNXQQwwzUfMF6EDz","market":"us","size":41719},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001518/limn-20250331xs1a002.jpg","primary":false,"translateUrl":"","linkName":"limn-20250331xs1a002.jpg","type":"GRAPHIC","id":"NTFILEBTwrXNruX9oQPNjS","market":"us","size":26044},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001518/limn-20250331xs1a003.jpg","primary":false,"translateUrl":"","linkName":"limn-20250331xs1a003.jpg","type":"GRAPHIC","id":"NTFILE4DpiShA76SCvqVqV","market":"us","size":67386},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001518/limn-20250331xex5d1001.jpg","primary":false,"translateUrl":"","linkName":"limn-20250331xex5d1001.jpg","type":"GRAPHIC","id":"NTFILEGSPVCmihDZQzRvqq","market":"us","size":3534},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001518/limn-20250331xex5d1002.jpg","primary":false,"translateUrl":"","linkName":"limn-20250331xex5d1002.jpg","type":"GRAPHIC","id":"NTFILEGWsqQkjZGJf8GGGV","market":"us","size":6920}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[修订]招股说明书","pubTime":"2025-07-26 09:59","pubTimestamp":1753495148,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20195015","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925070940-LIMN","pdf_url":"","pub_time":1753495088000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"LIMN","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1971387/0001104659-25-070940-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925070940/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILECNizE2DcSeK3acuK","market":"us","size":10918},{"description":"GRAPHIC","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925070940/image_001.jpg","primary":false,"translateUrl":"","linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILEG8wrUMmnrwuuNgXD","market":"us","size":3410}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2025-07-26 09:58","pubTimestamp":1753495088,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19888426","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925068670-LIMN","pdf_url":"","pub_time":1752724800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"LIMN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925068670/0001104659-25-068670-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925068670/tm2521089d1_8k.htm","primary":true,"translateUrl":"","linkName":"tm2521089d1_8k.htm","type":"8-K","id":"NTFILE4xLS6YKKA4xVWW2i","market":"us","size":29611}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-07-17 12:00","pubTimestamp":1752724800,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities","summary_zh":"第1.01项：签订重大最终协议；第3.02项：未经登记出售股本证券","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19871950","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925067444-LIMN","pdf_url":"","pub_time":1752206400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"LIMN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925067444/0001104659-25-067444-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925067444/tm2520692d1_8k.htm","primary":true,"translateUrl":"","linkName":"tm2520692d1_8k.htm","type":"8-K","id":"NTFILE5GyrpSsnxomPoh1Y","market":"us","size":30185}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-07-11 12:00","pubTimestamp":1752206400,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19845944","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465925065663-LIMN","pdf_url":"","pub_time":1751515200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"LIMN","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925065663/0001104659-25-065663-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000110465925065663/tm2519876d1_8k.htm","primary":true,"translateUrl":"","linkName":"tm2519876d1_8k.htm","type":"8-K","id":"NTFILEEXRMGW9Zaag5Gvd4","market":"us","size":33487}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-07-03 12:00","pubTimestamp":1751515200,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events","summary_zh":"项目8.01：其他事项","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19803845","market":"us","labels":[],"media":"sec.gov","original_id":"AN141057825001432-LIMN","pdf_url":"","pub_time":1750737600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1 - General form for registration of securities under the Securities Act of 1933","symbol":"LIMN","title":"Form S-1 - General form for registration of securities under the Securities Act of 1933","titleType":"招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001432/0001410578-25-001432-index.htm","us_notice_code":"Form S-1","us_title_en":"Form S-1 - General form for registration of securities under the Securities Act of 1933","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001432/limn-20250331xs1.htm","primary":true,"translateUrl":"","linkName":"limn-20250331xs1.htm","type":"S-1","id":"NTFILEF6DENEBb4rzJR3NT","market":"us","size":5259097},{"description":"EX-5.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001432/limn-20250331xex5d1.htm","primary":false,"translateUrl":"","linkName":"limn-20250331xex5d1.htm","type":"EX-5.1","id":"NTFILEBXXC59f2cEMRHG9Q","market":"us","size":21352},{"description":"EX-23.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001432/limn-20250331xex23d1.htm","primary":false,"translateUrl":"","linkName":"limn-20250331xex23d1.htm","type":"EX-23.1","id":"NTFILE9hRM88b4uEscmRcq","market":"us","size":4488},{"description":"EX-23.2","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001432/limn-20250331xex23d2.htm","primary":false,"translateUrl":"","linkName":"limn-20250331xex23d2.htm","type":"EX-23.2","id":"NTFILE5Ayud9pQsvh3KFkV","market":"us","size":4698},{"description":"EX-23.3","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001432/limn-20250331xex23d3.htm","primary":false,"translateUrl":"","linkName":"limn-20250331xex23d3.htm","type":"EX-23.3","id":"NTFILE8VWV2dfK1NLjEC5N","market":"us","size":4786},{"description":"EX-FILING FEES","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001432/limn-20250331xexfees.htm","primary":false,"translateUrl":"","linkName":"limn-20250331xexfees.htm","type":"EX-FILING FEES","id":"NTFILEFNZiyfQ6rP33eqS6","market":"us","size":41631},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001432/limn-20250331xs1002.jpg","primary":false,"translateUrl":"","linkName":"limn-20250331xs1002.jpg","type":"GRAPHIC","id":"NTFILE8kNUVdTr5RuZt4bZ","market":"us","size":26044},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001432/limn-20250331xs1003.jpg","primary":false,"translateUrl":"","linkName":"limn-20250331xs1003.jpg","type":"GRAPHIC","id":"NTFILE4Xr1bhA55Ep3vUnt","market":"us","size":67386},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001432/limn-20250331xex5d1001.jpg","primary":false,"translateUrl":"","linkName":"limn-20250331xex5d1001.jpg","type":"GRAPHIC","id":"NTFILECYQ378zaXiYiUvAH","market":"us","size":4313},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1971387/000141057825001432/limn-20250331xex5d1002.jpg","primary":false,"translateUrl":"","linkName":"limn-20250331xex5d1002.jpg","type":"GRAPHIC","id":"NTFILEGjBqaRbfNgPcdULn","market":"us","size":2096}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"招股说明书","pubTime":"2025-06-24 12:00","pubTimestamp":1750737600,"title_zh":"Form S-1 - General form for registration of securities under the Securities Act of 1933","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"stockEarnings":[{"period":"1week","weight":0.1776},{"period":"1month","weight":0.7353},{"period":"3month","weight":0.0769},{"period":"6month","weight":-0.6942},{"period":"1year","weight":-0.8913},{"period":"ytd","weight":1.0656}],"compareEarnings":[{"period":"1week","weight":0.0038},{"period":"1month","weight":-0.0028},{"period":"3month","weight":0.0128},{"period":"6month","weight":0.0731},{"period":"1year","weight":0.1443},{"period":"ytd","weight":0.015}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Liminatus Pharma, Inc.是一家特拉华州公司，成立于2022年11月23日。Liminatus是一家临床前阶段的生物制药公司，开发新型的免疫调节癌症疗法。公司候选IBA101，是一种人源化抗CD47单抗。下一代CD47检查点抑制剂的初步适应症预计为包括非小细胞肺癌在内的晚期实体癌患者。作为一家全球领先的生物制药公司，该公司的愿景是为癌症患者开发一系列广泛的变革性疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.012085},{"month":2,"riseRate":1,"avgChangeRate":0.270253},{"month":3,"riseRate":0.5,"avgChangeRate":-0.065679},{"month":4,"riseRate":0.5,"avgChangeRate":-0.073295},{"month":5,"riseRate":0.25,"avgChangeRate":-0.001827},{"month":6,"riseRate":0.6,"avgChangeRate":0.20484},{"month":7,"riseRate":0.4,"avgChangeRate":-0.094814},{"month":8,"riseRate":0.2,"avgChangeRate":-0.116647},{"month":9,"riseRate":0.4,"avgChangeRate":-0.076627},{"month":10,"riseRate":0.6,"avgChangeRate":-0.02675},{"month":11,"riseRate":0.4,"avgChangeRate":-0.052841},{"month":12,"riseRate":0.6,"avgChangeRate":-0.075377}],"exchange":"NASDAQ","name":"Liminatus Pharma LLC","nameEN":"Liminatus Pharma LLC"},"aProfile":null}}}